|
1
|
Webster AC, Nagler EV, Morton RL and
Masson P: Chronic kidney disease. Lancet. 389:1238–1252. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Wing MR, Ramezani A, Gill HS, Devaney JM
and Raj DS: Epigenetics of progression of chronic kidney disease:
Fact or fantasy? Semin Nephrol. 33:363–374. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Li Z, Liu X, Wang B, Nie Y, Wen J, Wang Q
and Gu C: Pirfenidone suppresses MAPK signaling pathway to reverse
epithelial-mesenchymal transition and renal fibrosis. Nephrology
(Carlton). 22:589–597. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Bani-Hani AH, Campbell MT, Meldrum DR and
Meldrum KK: Cytokines in epithelial-mesenchymal transition: A new
insight into obstructive nephropathy. J Urol. 180:461–468. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Liu Y: Epithelial to mesenchymal
transition in renal fibrogenesis: Pathologic significance,
molecular mechanism, and therapeutic intervention. J Am Soc
Nephrol. 15:1–12. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Winter J, Jung S, Keller S, Gregory RI and
Diederichs S: Many roads to maturity: MicroRNA biogenesis pathways
and their regulation. Nat Cell Biol. 11:228–234. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Chen Y, Song YX and Wang ZN: The
microRNA-148/152 family: Multi-faceted players. Mol Cancer.
12:432013. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Miao CG, Yang YY, He X, Huang C, Huang Y,
Qin D, Du CL and Li J: MicroRNA-152 modulates the canonical Wnt
pathway activation by targeting DNA methyltransferase 1 in
arthritic rat model. Biochimie. 106:149–156. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Wu Y, Huang A, Li T, Su X, Ding H, Li H,
Qin X, Hou L, Zhao Q, Ge X, et al: miR-152 reduces human umbilical
vein endothelial cell proliferation and migration by targeting
ADAM17. FEBS Lett. 588:2063–2069. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Chandrasekaran K, Karolina DS, Sepramaniam
S, Armugam A, Wintour EM, Bertram JF and Jeyaseelan K: Role of
microRNAs in kidney homeostasis and disease. Kidney Int.
81:617–627. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Gregory PA, Bert AG, Paterson EL, Barry
SC, Tsykin A, Farshid G, Vadas MA, Khew-Goodall Y and Goodall GJ:
The miR-200 family and miR-205 regulate epithelial to mesenchymal
transition by targeting ZEB1 and SIP1. Nat Cell Biol. 10:593–601.
2008. View
Article : Google Scholar : PubMed/NCBI
|
|
12
|
Park SM, Gaur AB, Lengyel E and Peter ME:
The miR-200 family determines the epithelial phenotype of cancer
cells by targeting the E-cadherin repressors ZEB1 and ZEB2. Genes
Dev. 22:894–907. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Chen CH, Cheng CY, Chen YC, Sue YM, Liu
CT, Cheng TH, Hsu YH and Chen TH: MicroRNA-328 inhibits renal
tubular cell epithelial-to-mesenchymal transition by targeting the
CD44 in pressure-induced renal fibrosis. PLoS One. 9:e998022014.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Kato M, Zhang J, Wang M, Lanting L, Yuan
H, Rossi JJ and Natarajan R: MicroRNA-192 in diabetic kidney
glomeruli and its function in TGF-beta-induced collagen expression
via inhibition of E-box repressors. Proc Natl Acad Sci USA.
104:3432–3437. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Yin S, Zhang Q, Yang J, Lin W, Li Y, Chen
F and Cao W: TGFβ-incurred epigenetic aberrations of miRNA and DNA
methyltransferase suppress Klotho and potentiate renal fibrosis.
Biochim Biophys Acta. 1864:1207–1216. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Huang Y, Tong J, He F, Yu X, Fan L, Hu J,
Tan J and Chen Z: miR-141 regulates TGF-β1-induced
epithelial-mesenchymal transition through repression of HIPK2
expression in renal tubular epithelial cells. Int J Mol Med.
35:311–318. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Lan A, Qi Y and Du J: Akt2 mediates
TGF-β1-induced epithelial to mesenchymal transition by deactivating
GSK3β/snail signaling pathway in renal tubular epithelial cells.
Cell Physiol Biochem. 34:368–382. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Li SS, Liu QF, He AL and Wu FR: Tranilast
attenuates TGF-β1-induced epithelial-mesenchymal transition in the
NRK-52E cells. Pak J Pharm Sci. 27:51–55. 2014.PubMed/NCBI
|
|
19
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Feng Y, Li L, Zhang X, Zhang Y, Liang Y,
Lv J, Fan Z, Guo J, Hong T, Ji B, et al: Hematopoietic pre-B cell
leukemia transcription factor interacting protein is overexpressed
in gastric cancer and promotes gastric cancer cell proliferation,
migration, and invasion. Cancer Sci. 106:1313–1322. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Hudson BG, Tryggvason K, Sundaramoorthy M
and Neilson EG: Alport's syndrome, Goodpasture's syndrome, and type
IV collagen. N Engl J Med. 348:2543–2556. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Zeisberg M, Strutz F and Muller GA: Renal
fibrosis: An update. Curr Opin Nephrol Hypertens. 10:315–320. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Ng YY, Huang TP, Yang WC, Chen ZP, Yang
AH, Mu W, Nikolic-Paterson DJ, Atkins RC and Lan HY: Tubular
epithelial-myofibroblast transdifferentiation in progressive
tubulointerstitial fibrosis in 5/6 nephrectomized rats. Kidney Int.
54:864–876. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Zeisberg M, Hanai J, Sugimoto H, Mammoto
T, Charytan D, Strutz F and Kalluri R: BMP-7 counteracts
TGF-beta1-induced epithelial-to-mesenchymal transition and reverses
chronic renal injury. Nat Med. 9:964–968. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Thuault S, Valcourt U, Petersen M,
Manfioletti G, Heldin CH and Moustakas A: Transforming growth
factor-beta employs HMGA2 to elicit epithelial-mesenchymal
transition. J Cell Biol. 174:175–183. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Bijkerk R, de Bruin RG, van Solingen C,
van Gils JM, Duijs JM, van der Veer EP, Rabelink TJ, Humphreys BD
and van Zonneveld AJ: Silencing of microRNA-132 reduces renal
fibrosis by selectively inhibiting myofibroblast proliferation.
Kidney Int. 89:1268–1280. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Loboda A, Sobczak M, Jozkowicz A and Dulak
J: TGF-β1/Smads and miR-21 in renal fibrosis and inflammation.
Mediators Inflamm. 2016:83192832016. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Chhabra R, Dubey R and Saini N:
Cooperative and individualistic functions of the microRNAs in the
miR-23a~27a~24-2 cluster and its implication in human diseases. Mol
Cancer. 9:2322010. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Yu G, Jia Z and Dou Z: miR-24-3p regulates
bladder cancer cell proliferation, migration, invasion and
autophagy by targeting DEDD. Oncol Rep. 37:1123–1131. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Roscigno G, Puoti I, Giordano I,
Donnarumma E, Russo V, Affinito A, Adamo A, Quintavalle C, Todaro
M, Vivanco MD and Condorelli G: MiR-24 induces chemotherapy
resistance and hypoxic advantage in breast cancer. Oncotarget.
8:19507–19521. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Lin F, Wu X, Zhang H, You X, Zhang Z, Shao
R and Huang C: A microrna screen to identify regulators of
peritoneal fibrosis in a rat model of peritoneal dialysis. BMC
Nephrol. 16:482015. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Bugide S, David D, Nair A, Kannan N,
Samanthapudi VS, Prabhakar J and Manavathi B: Hematopoietic
PBX-interacting protein (HPIP) is over expressed in breast
infiltrative ductal carcinoma and regulates cell adhesion and
migration through modulation of focal adhesion dynamics. Oncogene.
34:4601–4612. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
van Vuurden DG, Aronica E, Hulleman E,
Wedekind LE, Biesmans D, Malekzadeh A, Bugiani M, Geerts D, Noske
DP, Vandertop WP, et al: Pre-B-cell leukemia homeobox interacting
protein 1 is overexpressed in astrocytoma and promotes tumor cell
growth and migration. Neuro Oncol. 16:946–959. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Feng Y, Xu X, Zhang Y, Ding J, Wang Y,
Zhang X, Wu Z, Kang L, Liang Y, Zhou L, et al: HPIP is upregulated
in colorectal cancer and regulates colorectal cancer cell
proliferation, apoptosis and invasion. Sci Rep. 5:94292015.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Shi S, Zhao J, Wang J, Mi D and Ma Z: HPIP
silencing inhibits TGF-β1-induced EMT in lung cancer cells. Int J
Mol Med. 39:479–483. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Zhang GY, Liu AH, Li GM and Wang JR: HPIP
silencing prevents epithelial-mesenchymal transition induced by
TGF-β1 in human ovarian cancer cells. Oncol Res. 24:33–39. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Mai H, Xu X, Mei G, Hong T, Huang J, Wang
T, Yan Z, Li Y, Liang Y, Li L, et al: The interplay between HPIP
and casein kinase 1alpha promotes renal cell carcinoma growth and
metastasis via activation of mTOR pathway. Oncogenesis. 5:e2602016.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Xu X, Fan Z, Kang L, Han J, Jiang C, Zheng
X, Zhu Z, Jiao H, Lin J, Jiang K, et al: Hepatitis B virus X
protein represses miRNA-148a to enhance tumorigenesis. J Clin
Invest. 123:630–645. 2013.PubMed/NCBI
|
|
39
|
Bugide S, Gonugunta VK, Penugurti V,
Malisetty VL, Vadlamudi RK and Manavathi B: HPIP promotes
epithelial-mesenchymal transition and cisplatin resistance in
ovarian cancer cells through PI3K/AKT pathway activation. Cell
Oncol (Dordr). 40:133–144. 2017. View Article : Google Scholar : PubMed/NCBI
|
